We are live on
!
Find out more
Vanguard Group Portfolio holdings
AUM
$6.9T
1-Year Est. Return
27.45%
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Fund
S&P 500
This Quarter
Est. Return
+3.95%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$6.9T
AUM Growth
+$217B
(+3.3%)
Cap. Flow
+$87.2B
Cap. Flow
% of AUM
1.26%
Top 10 Holdings %
Top 10 Hldgs %
31.23%
Holding
4,426
New
82
Increased
2,421
Reduced
1,563
Closed
98
Avg Time Held
32.8
quarters
Top 10 Avg Time Held
19.5
quarters
Top 20 Avg Time Held
24.4
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$8.03B |
| 2 |
Microsoft
MSFT
|
+$8B |
| 3 |
Apple
AAPL
|
+$7.21B |
| 4 |
TotalEnergies
TTE
|
+$5.18B |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.85B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
K
Kellanova
K
|
+$2.74B |
| 2 |
DuPont de Nemours
DD
|
+$2.65B |
| 3 |
COOP
Mr. Cooper
COOP
|
+$1.41B |
| 4 |
IPG
Interpublic Group of Companies
IPG
|
+$1.24B |
| 5 |
Amazon
AMZN
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32% |
| 2 | Financials | 13.5% |
| 3 | Consumer Discretionary | 9.91% |
| 4 | Healthcare | 9.82% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4201
Marygold Companies
MGLD
$87.4M
| $74.5K | ﹤0.01% |
84,318
+2,055
| +2% | +$2.06K |
2025 Q3
1 quarter
|
|
|
AMZE
4202
DELISTED
AMAZE HOLDINGS INC
AMZE
| $70.5K | ﹤0.01% |
23,186
+16,128
| +229% | +$109K |
2025 Q3
1 quarter
|
|
|
RTB
4203
RTB Digital
RTB
$118M
| $70.2K | ﹤0.01% |
12,386
+6,655
| +116% | +$73.5K |
2021 Q2
18 quarters
|
|
4204
Iveda Solutions
IVDA
$3.41M
| $69.6K | ﹤0.01% |
82,828
+46,665
| +129% | +$52.1K |
2025 Q2
2 quarters
|
|
|
OPNW
4205
OpenWorld, Inc. Common Stock
OPNW
$59.9M
| $69K | ﹤0.01% |
11,484
| – | – |
2021 Q1
19 quarters
|
|
|
IHT
4206
InnSuites Hospitality Trust
IHT
$12.5M
| $68.9K | ﹤0.01% |
51,409
| – | – |
2021 Q2
18 quarters
|
|
4207
Sonoma Pharmaceuticals
SNOA
$5.89M
| $68.7K | ﹤0.01% |
18,887
-1,986
| -10% | -$7.33K |
2025 Q3
1 quarter
|
|
|
PURR
4208
Hyperliquid Strategies Inc
PURR
$2.2B
| $68.6K | ﹤0.01% |
+19,277
| New | +$66.8K |
2025 Q4
0 quarters
|
|
4209
Socket Mobile
SCKT
$5M
| $68.6K | ﹤0.01% |
67,874
| – | – |
2017 Q4
32 quarters
|
|
4210
Processa Pharmaceuticals
PCSA
$4.25M
| $67.9K | ﹤0.01% |
23,586
+12,058
| +105% | +$84.2K |
2020 Q4
20 quarters
|
|
4211
IN8bio
INAB
$13.2M
| $66.3K | ﹤0.01% |
28,348
-31,070
| -52% | -$59.1K |
2021 Q3
17 quarters
|
|
|
SGN
4212
DELISTED
Signing Day Sports
SGN
| $65.8K | ﹤0.01% |
69,610
| – | – |
2025 Q3
1 quarter
|
|
4213
Cardio Diagnostics
CDIO
$5.53M
| $65.4K | ﹤0.01% |
24,124
| – | – |
2023 Q1
11 quarters
|
|
4214
Kiora Pharmaceuticals
KPRX
$11.2M
| $65.2K | ﹤0.01% |
33,091
+12,176
| +58% | +$27.8K |
2025 Q3
1 quarter
|
|
|
SUNE
4215
SUNation Energy
SUNE
$14.8M
| $65.2K | ﹤0.01% |
63,291
| – | – |
2025 Q3
1 quarter
|
|
4216
Biofrontera
BFRI
$14.4M
| $65K | ﹤0.01% |
113,951
| – | – |
2025 Q3
1 quarter
|
|
|
SRXH
4217
SRX Global
SRXH
$29.6M
| $64K | ﹤0.01% |
4,679
+2,067
| +79% | +$39.8K |
2025 Q3
1 quarter
|
|
|
FAT
4218
DELISTED
FAT Brands
FAT
| $63.9K | ﹤0.01% |
203,006
-15,171
| -7% | -$18.2K |
2021 Q2
18 quarters
|
|
|
USBC
4219
USBC Inc
USBC
$198M
| $61.9K | ﹤0.01% |
+97,444
| New | +$81.9K |
2025 Q4
0 quarters
|
|
4220
DSS Inc
DSS
$6.08M
| $60.2K | ﹤0.01% |
64,834
| – | – |
2013 Q2
50 quarters
|
|
4221
Aterian
ATER
$11M
| $58.8K | ﹤0.01% |
84,615
-91,054
| -52% | -$79.5K |
2019 Q3
25 quarters
|
|
4222
ENDRA Life Sciences
NDRA
$8.19M
| $58.6K | ﹤0.01% |
+12,937
| New | +$73.8K |
2025 Q4
0 quarters
|
|
4223
Arts-Way Manufacturing Co
ARTW
$18.4M
| $58.5K | ﹤0.01% |
24,894
-1,481
| -6% | -$3.64K |
2023 Q3
9 quarters
|
|
4224
Acurx Pharmaceuticals
ACXP
$5.46M
| $58K | ﹤0.01% |
+23,280
| New | +$112K |
2025 Q4
0 quarters
|
|
|
AGIG
4225
Abundia Global Impact Group
AGIG
$41.9M
| $58K | ﹤0.01% |
29,274
| – | – |
2020 Q4
20 quarters
|
|
Similar funds
CWM
FAF
BGIM
CIM
UOC
Vanguard Group's Q4 2025 Portfolio in Review
As of Q4 2025, Vanguard Group held 4,426 positions worth $6.9T, up 3.3% from $6.68T the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 4.1%. Vanguard Group opened 82 new positions and exited 98, leaving the 4,426-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vanguard Group's largest Q4 2025 buy was TotalEnergies: 81,863,403 shares worth $5.34B.
- Vanguard Group added most to NVIDIA in Q4 2025, an estimated $8.03B increase.
- Vanguard Group's biggest Q4 2025 reduction was DuPont de Nemours, cutting an estimated $2.65B.
- Vanguard Group fully exited Kellanova in Q4 2025, selling an estimated $2.74B.
- Vanguard Group's ten largest holdings make up 31% of its $6.9T portfolio in Q4 2025.
- Vanguard Group opened 82 new positions and closed 98 in Q4 2025.
- Vanguard Group's portfolio value rose 3.3% quarter-over-quarter to $6.9T.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.